Table 4 Multivariate analysis of risk factors for recurrence of pulmonary adenocarcinoma
From: The importance of the lepidic component as a prognostic factor in stage I pulmonary adenocarcinoma
HR | 95 % CI | p value | |
|---|---|---|---|
Age | 0.960 | 0.911–1.011 | 0.120 |
Sex | 0.678 | 0.161–2.853 | 0.597 |
Smoking history | 1.006 | 0.974–1.039 | 0.714 |
SUVmax | 1.011 | 0.860–1.189 | 0.893 |
Tumor size | 1.456 | 0.715–2.965 | 0.300 |
Pleural invasion | 0.469 | 0.117–1.874 | 0.284 |
Lymphatic invasion | 2.487 | 0.677–9.134 | 0.170 |
Vascular invasion | 1.496 | 0.321–6.960 | 0.608 |
Lepidic component (%) | 0.955 | 0.924–0.987 | 0.007 |
Micropapillary component (%) | 1.040 | 0.991–1.092 | 0.114 |
Acinar component (%) | 1.012 | 0.993–1.032 | 0.209 |
Papillary component (%) | 1.016 | 0.994–1.038 | 0.155 |
Solid component (%) | 0.982 | 0.927–1.041 | 0.546 |
Lepidic component ≤10 % | 5.806 | 1.666–20.238 | 0.006 |